T Gallant
Overview
Explore the profile of T Gallant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gallant T, Boyden M, Gallant L, Carley H, Freedman M
Am J Med
. 1987 Dec;
83(6):1085-90.
PMID: 3503576
Visual and auditory neurotoxicity was previously documented in 42 of 89 patients with transfusion-dependent anemia who were receiving iron chelation therapy with daily subcutaneous deferoxamine. Twenty-two patients in the affected...
2.
Sutton T, Gallant T, Griese G
Wis Med J
. 1987 Dec;
86(12):13-5.
PMID: 3424859
No abstract available.
3.
Taylor M, Keenan N, Gallant T, Skarf B, Freedman M, Logan W
Electroencephalogr Clin Neurophysiol
. 1987 Mar;
68(2):81-7.
PMID: 2435533
As deferoxamine (DFO) appeared to have certain toxic effects on the sensory pathways in some of our patients on nightly subcutaneous deferoxamine (DFO) for transfusion-dependent anemia, treatment was stopped in...
4.
Gallant T, Freedman M, Vellend H, FRANCOMBE W
N Engl J Med
. 1986 Jun;
314(25):1643.
PMID: 3713766
No abstract available.
5.
Olivieri N, Buncic J, Chew E, Gallant T, Harrison R, Keenan N, et al.
N Engl J Med
. 1986 Apr;
314(14):869-73.
PMID: 3485251
Of 89 patients receiving nightly subcutaneous deferoxamine for transfusion-dependent thalassemia major or Diamond-Blackfan anemia, 13 presented with visual loss or deafness of acute onset or both. Detailed ophthalmologic, audiologic, and...
6.